HARVARD BIOSCIENCE, INC. Increase (Decrease) in Equity Securities, FV-NI
HARVARD BIOSCIENCE, INC. (HBIO) reported Increase (Decrease) in Equity Securities, FV-NI of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi · last filed 2024-03-07
- HARVARD BIOSCIENCE, INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2023-12-31 was $0.00.
- HARVARD BIOSCIENCE, INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2023-09-30 was $0.00.
- HARVARD BIOSCIENCE, INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2022-12-31 was $0.00.
- HARVARD BIOSCIENCE, INC. increase (decrease) in equity securities, fv-ni for the quarter ending 2022-09-30 was $0.00.
- HARVARD BIOSCIENCE, INC. increase (decrease) in equity securities, fv-ni for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. increase (decrease) in equity securities, fv-ni for fiscal 2022 was $3.90M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in equity securities, fv-ni for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Equity Securities, FV-NI 3 month | Increase (Decrease) in Equity Securities, FV-NI 6 month | Increase (Decrease) in Equity Securities, FV-NI 9 month | Increase (Decrease) in Equity Securities, FV-NI 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $3.90M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.90M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $3.90M 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $0.00 10-K · filed 2023-03-09 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |